Page last updated: 2024-09-04

vatalanib and sesquiterpenes

vatalanib has been researched along with sesquiterpenes in 3 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(sesquiterpenes)
Trials
(sesquiterpenes)
Recent Studies (post-2010) (sesquiterpenes)
276429817,4895367,668

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Drevs, J; Hofmann, I; Hugenschmidt, H; Madjar, H; Marmé, D; Martiny-Baron, G; Müller, M; Unger, C; Wittig, C; Wood, J1
Filov, VA; Gershanovich, ML; Imianitov, EN; Stukov, AN1
Li, G; Li, P; Liu, H; Luo, X; Sung, PJ; Tang, X; Wang, Q1

Reviews

1 review(s) available for vatalanib and sesquiterpenes

ArticleYear
[Problems in the current target therapy of malignancies].
    Voprosy onkologii, 2005, Volume: 51, Issue:5

    Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab

2005

Other Studies

2 other study(ies) available for vatalanib and sesquiterpenes

ArticleYear
Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
    Cancer research, 2000, Sep-01, Volume: 60, Issue:17

    Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Cell Division; Cyclohexanes; Disease Models, Animal; Enzyme Inhibitors; Female; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Renal Circulation; Sesquiterpenes

2000
Clavukoellians G-K, New Nardosinane and Aristolane Sesquiterpenoids with Angiogenesis Promoting Activity from the Marine Soft Coral
    Marine drugs, 2020, Mar-20, Volume: 18, Issue:3

    Topics: Angiogenesis Inducing Agents; Animals; Animals, Genetically Modified; Anthozoa; Biological Products; Blood Vessels; China; Magnetic Resonance Spectroscopy; Models, Animal; Molecular Structure; Neovascularization, Physiologic; Phthalazines; Pyridines; Sesquiterpenes; Zebrafish

2020